quinacrine has been researched along with sb 218078 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Das, D; Das, S; Kundu, CN; Nayak, A; Preet, R; Satapathy, SR; Siddharth, S; Wyatt, MD | 1 |
1 other study(ies) available for quinacrine and sb 218078
| Article | Year |
|---|---|
Chk1 inhibitor synergizes quinacrine mediated apoptosis in breast cancer cells by compromising the base excision repair cascade.
Topics: Alkaloids; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Checkpoint Kinase 1; DNA Repair; Drug Synergism; Female; Humans; Protein Kinases; Quinacrine | 2016 |